Non-enzymic binding of sugars to proteins (glycation) is a common biological phenomenon t-hat is increased in diabetesMost wor.k has been directed towards structural proteins which may be present for many years and would continue to accumulate sugar residues. As glycation is a non-specific reaction, other proteins such as enzymes will also be susceptible to glycation and could well display altered activity. We investigated the effect of various sugars whose concentrations increase in diabetes in insulin-independent tissues on glutathione reductase, an enzyme that maintains the GSH level in cells. Glucose, glucose 6-phosphate and fructose all displayed a time-dependent inhibition of glutathione reductase activity, suggesting that these sugars glycate this enzyme. Aspirin gave some protection against the loss of activity induced by glucose.
INTRODUCTION
Non-enzymic glycosylation (glycation) was first described by Louis Maillard (1912) , who observed browning of amino acids when they were heated with sugars. The 'Maillard reaction' was not shown to be important outside the food industry for many decades. The first protein demonstrated to be glycated in vivo was haemoglobin. Bookchin & Gallop (1968) showed that there was a hexose molecule linked to the N-terminal valine of the ,-chain of HbAlc, a minor component of haemoglobin that increases in diabetes in humans (Rahbar et al., 1969) and in animals (Koenig & Cerami, 1975) . Fliickiger & Winterhalter (1976) .formed HbAlc in vitro by incubating haemoglobin with glucose. Other sugars, such as glucose 6-phosphate and fructose 1,6-bisphosphate, bind to haemoglobin in vivo (Bunn et al., 1978) . Many other plasma and structural proteins have been shown to be glycated in vivo with increases in diabetes (van Boekel, 1991) .
The level of glycation of plasma proteins is limited by their rapid replacement. However, structural proteins that are present for many years, or even decades, such as crystallins at the centre of the lens, where there is little or no synthesis of new protein (Harding, 1991) , will continue to accumulate sugar residues. Glycation impairs the function of some proteins. For example it shifts the haemoglobin-oxygen dissociation curve, possibly compromising oxygen delivery to cells (Standl & Kolb, 1973; Ditzel et al., 1978) ; it alters the ligand-binding properties of albumin (Shaklai et al., 1984) and decreases clearance of lowdensity lipoproteins, owing to the decrease in its ability to interact with fibroblast receptors (Sasaki et al., 1982) . Disruption of the surface network of charges of lens crystallins by glycation could lead to protein unfolding (Beswick & Harding, 1987) , exposing thiol groups, which could become involved 'in both intra-and inter-molecular cross-linking, leading to highmolecular-mass aggregates which scatter light (Harding, 1973; Perry et al., 1987) . Glycation has also been implicated in complications associated with diabetes seen in the kidney basement membrane (Uitto et al., 1982) , myelin in the peripheral and central nervous system (Vlassara et al., 1983) , osteoporosis and osteopenia (Gundberg et al., 1986) .
Most interest in glycation has been directed towards structural proteins, but other proteins, such as enzymes, will be susceptible to glycation and may have their activity inhibited through blockage of the active site itself or by structural alteration which in turn affects the active site. The enzyme superoxide dismutase (SOD) from the plasma has been shown to be glycated' in vivo, the proportion of glycated SOD being considerably higher in diabetic patients (Adachi et al., 1991) . The enzyme activity was not affected, suggesting that the glycation site(s) was rather far away from the active site. However, glycation did affect affinity for heparin, which could decrease the amount of SOD bound to the cell surface, which in turn would increase the susceptibility of cells to superoxide radicals produced in the extracellular space. Glycation of Nal + K+-ATPase alters the kinetics of this ion pump (Garner & Spector, 1986 ).
Glutathione reductase maintains the level of GSH in cells. The content of this biological reducing agent decreases steadily with age in mouse erythrocytes, liver, kidney and heart (Abraham et al., 1978; Hazelton & Lang, 1980) , in rat liver, heart, brain, lung and spleen (Farooqui et al., 1987) and in human lens and erythrocytes (Harding, 1970; Matsubara & Machado, 1991) . A further decrease occurs in human cataract (Harding, 1970) and, indeed, in almost all experimental cataracts (Harding, 1991) . Opacification of lens protein solutions treated with hexose was diminished by GSH (Stevens et al., 1978) , and GSH offered protection against cataract in diabetic rats (Ross et al., 1983) . The degree of decrease in GSH content of the lens correlated with the increased opacification in diabetic rats (Blakytny & Harding, 1992) .
It is possible that this inability to maintain GSH could result from loss of glutathione reductase activity. Decrease in activity of this enzyme has been demonstrated in tandem with GSH loss on aging in various tissues in mouse (Abraham et al., 1978) , rats (Farooqui et al., 1987) and human erythrocytes (Al-Turk et al., 1987) . Activity of glutathione reductase in erythrocytes is significantly decreased in both diabetic adults (Murakami et al., 1989) and children (St'ahlberg & Hietanen, 1991) . Decrease in enzyme activity has also been observed in mature, nuclear and cortical human cataracts (Friedburg & Manthey, 1973; Rogers & Augusteyn, 1978; Ohrloff et al., 1984) .
To determine whether the loss of GSH in diabetes is due to the inhibition of glutathione reductase through glycation, the bovine intestinal enzyme was incubated with glucose, glucose 6-phosphate and fructose, all ofwhich are elevated in some tissues in diabetes (Gonzalez et al., 1980; Jedziniak et al., 1981; Mayhew Abbreviation used: SOD, superoxide dismutase.
Vol. 288 et al., 1983) . Sorbitol, lacking the carbonyl group required for glycation, was used as a control, and ethanediol was used to check whether any inhibition of enzyme activity was due to changes in osmolarity of the incubation medium. Aspirin and ibuprofen decrease glycation in vitro (Day et al., 1979;  Huby Ajiboye & Harding, 1989; Raza & Harding, 1991) and in vivo in rats (Rendell et al., 1986; Swamy & Abraham, 1989; Blakytny & Harding, 1992) and also partly maintain GSH levels in the lenses of streptozotocin-induced diabetic rats (Blakytny & Harding, 1992) . In the present work we also investigated whether these analgesics protected glutathione reductase against inactivation by sugars. Paracetamol was also studied; this analgesic, along with aspirin and ibuprofen, protect against cataract in diabetic rats (Swamy & Abraham, 1989; Blakytny & Harding, 1992) and are associated with a protective effect against cataract in man (van Heyningen & Harding, 1986; Harding & van Heyningen, 1988; Harding et al., 1989; Mohan et al., 1989) , although there is some controversy over their protective role (Harding, 1991; Isaac et al., 1991; Seddon et al., 1991) .
MATERIALS AND METHODS Materials
Bovine intestinal glutathione reductase, NADPH and colorimetric glucose assay kit were obtained from Sigma (Poole, Dorset, U.K.). Sil-Prep was obtained from Applied Science (State College, PA, U.S.A.). The capillary column for gas chromatography was from Scientific Glass Engineering (Milton Keynes, Bucks, U.K.). D-[14C]Sorbitol was from du Pont U.K.
(Stevenage, Herts., U.K.). All other chemicals were obtained from Sigma or BDH (Lutterworth, Leics., U.K.).
Glutathione reductase
The enzymic activity of bovine intestinal glutathione reductase was determined by measuring the decrease in absorption at 339 nm on.a Perkin-Elmer 55 u.v.-visible spectrophotometer as NADPH was used to reduce GSSG. The assay was based on that described by Bergmeyer (1987) , with slight modifications. First 0.1 ml of 15 mM-EDTA, 0.1 ml of 63.5 mM-GSSG and enzyme solution (5 units/ml of buffer) were added to 2.73 ml of 0.12 M-potassium phosphate buffer, pH 7.2, at 37°C (1.0 MNaOH was added to KH2PO4). The solution was incubated in a water bath at 37°C for 4.5 min, then pipetted into a quartz cuvette in the spectrophotometer and 50 ul of 9.6 mM-NADPH [in 1 % (w/v) NaHCO3] was added 5 min after the start of the incubation, stirred rapidly and the absorbance continuously monitored against a water blank (absorption range 0-1.0; response 2; slit width 2 nm; chart speed 2 cm/min). All enzyme activities were calculated from the decrease in the absorption between 0.5 and 1.5 min.
Incubation of enzyme with sugars
To determine whether various sugars affected the activity of glutathione reductase, the enzyme was incubated in the pH 7 Binding of sorbitol to soluble bovine lens proteins Two bovine lenses (total 2.9 g) were decapsulated and homogenized in 12 times their weight of 2 mM-sodium pyrophosphate buffer, pH 7.4. After centrifugation at 12000 g for 20 min, the supernatant was dialysed three times against water (2 litres) over 3 h and then freeze-dried for storage at -20°C .
The reaction mixture consisted of 10 mg of protein dissolved in 0.1 M-sodium pyrophosphate buffer, pH 7.4, 2.5 mg of NaN3 (to inhibit organic growth), 5 mM-EDTA in 0.5 ml of buffer, 50 mM-sorbitol in 1 ml of buffer, 0.1 ml of radiolabelled sorbitol (sp. radioactivity 342 ,Ci/mmol) and 0.9 ml of buffer, pH 7.4, to give a reaction volume of 5 ml. All solids were weighed into sterilized containers. On mixing the reaction solution it was immediately passed through a 0.2 pm-pore-size sterilized Millipore filter into an autoclaved sealed container via a sterilized needle and placed in a shaking water bath at 37 'C. A sample of 0.3 ml was immediately withdrawn by sterilized needle and syringe. From this four 10 pl samples were taken and placed in scintillation vials to which 3.5 ml of Scintran cocktail T was added. Total radioactivity in the vials was measured on a 1992 scintillation counter to calculate the total radiolabel in the reaction mixture. Four aliquots (50 ,ul) were precipitated overnight in 1 ml of 10% (w/v) trichloroacetic acid at 4 'C. The precipitates were retained on Whatman GF/C microfibre filter discs by suction and washed with 5 % trichloroacetic acid. The discs were inserted into scintillation vials, dried at 70 'C for 30 min and allowed to cool at room temperature; 3.5 ml Scintran cocktail T was added and the radioactivity was measured on a scintillation counter. At various times a 225 ,1 portion was similarly removed and subdivided into 50 ,u aliquots to determine binding.
RESULTS

Experiments with 0.5 M-sugars
There was no immediate inhibition of enzyme activity by glucose, glucose 6-phosphate, fructose or sorbitol, zero time activity not being different from that of the control (Fig. 1) . Therefore these sugars are not active as inhibitors in the usual sense. The three sugars and sorbitol did, however, display a timedependent inhibition of enzyme activity (Fig. 1) , suggesting nonenzymic binding to the protein molecule. Fructose had the most rapid effect. Inhibition by sorbitol was unexpected, as it should not react with proteins, since it lacks a carbonyl group and was included as a sugar control Ethanediol did not display an inhibitory effect (results not shown), suggesting that the sugars are not inhibiting the enzyme through increased osmolarity.
Experiments with 5 mM-sugars
Even at this much lower concentration, more representative of conditions in vivo, at least during diabetes, all four sugars demonstrated a time-dependent inhibition of glutathione reductase activity (Fig. 2) . Both fructose and glucose 6-phosphate had significantly lowered enzyme activity after 2 days [17.2+25.4% (mean+s.D.) of initial activity; P <0.01; 61.0 + 17.6 %, P < 0.025 by Student's t test respectively], fructose being more effective than glucose 6-phosphate (P < 0.05). Glucose displayed a slower inhibitory effect, which was statistically significant after 5 days (48.2 + 32.0 %; P < 0.05), although not significantly different from fructose or glucose 6-phosphate in its inhibition at this stage. Sorbitol displayed a considerable delay, not being statistically significantly lower until 9 days of incubation (74.8 + 13.9 %; P < 0.05). With time the differences in inhibition by the sugars decrease, with that of both fructose and glucose 6-phosphate being significantly lower than that of sorbitol after 5 days (P < 0.005), whereas, by the end of the incubation (15 days), only that of fructose was still significantly lower than that of sorbitol (P < 0.05). It would seem that the three glycating sugars display non-enzymic binding to protein (glutathione reductase), but at different rates. The effect of sorbitol had to be examined more closely (see below).
Incubation with drugs
Aspirin, paracetamol and ibuprofen did not display any protection against the four compounds (results not shown) except that 20 mM-aspirin gave some protection against glucose. Until the end of the incubation with glucose, the activity was higher in the presence of aspirin. To confirm that this was a real protective effect, the incubation was repeated two further times. The combined data of the three incubations (Fig. 3) showed that aspirin provided protection against inhibition of enzyme activity by 5 mM-glucose over most of the 15 days of the experiments, being statistically significant after 5 days (P < 0.05 by Student's t test). However, aspirin did not maintain the activity at the level of the controls. Aspirin itself did not affect the activity in the absence of sugar (Fig. 3) . The sugars used were: 0, glucose; 0, glucose 6-phosphate; A, fructose; *, sorbitol. All points were calculated from the means of three sets of readings for glucose and triplicates for the other sugars. (which is chemically reduced to produce sorbitol) or for other contaminating sugars. The glucose oxidase method indicated less than 1 00 of glucose was present. As expected, with the g.l.c. method, a single peak was found with no shoulders for sorbitol (Fig. 4) , which came off later than the glucose peak, the latter having shoulders for the various possible derivatives (results not shown). Fructose also gave a peak with multiple shoulders. These results indicate that the sorbitol used was free of reactive glycating sugars and therefore that the inhibitory effect is due to the sorbitol itself.
When radiolabelled sorbitol was incubated with lens proteins there was relatively little binding of sorbitol to the proteins, and this was all over long before sorbitol started to affect glutathione reductase activity ( Fig. 5; cf. Fig. 2) . After 150 h, 60 mmol of sorbitol was bound/mol of protein, whereas in a similar experiment with glucose 6-phosphate, 240 mmol of the sugar were bound/mol of protein. The rapid initial sorbitol binding which does not increase further with time ( Fig. 5) would suggest that this is non-specific, whereas glucose 6-phosphate binding continues to increase with time (results not shown), being indicative of glycation.
DISCUSSION
The time-dependent inhibition of bovine intestinal glutathione reductase by glucose, glucose 6-phosphate and fructose suggests that these sugars bind non-enzymically to this enzyme. The possibility that the sugars act by exerting an osmotic effect was ruled out by the lack of inhibition by ethanediol. The rate of glycation is dependent on the percentage of sugar in the openchain form, in which the carbonyl group is available for Schiffbase formation. The percentage for fructose is greater than that of glucose, being reflected in the former's greater reactivity with haemoglobin (Bunn & Higgins, 1991) , hence fructose's more rapid inhibition of glutathione reductase activity. The more rapid inhibition by glucose 6-phosphate compared with glucose may be due to the phosphate group adding to the disruption of the enzyme, as has been suggested for the unfolding of y-crystallin (Beswick & Harding, 1987) .
The inhibitory effect of sorbitol cannot be explained in terms of it glycating the enzyme, owing to its lack of a carbonyl group. Although some initial binding was observed when using radiolabelled sorbitol and total bovine lens proteins, this occurred before sorbitol displayed any inhibitory effect on the enzyme, and the degree of binding did not alter with time. Sugar contaminants were not found using both colorimetric and g.l.c. methods.
Glycation of free amino groups in tivo has been shown to display a preference for lysyl-lysine sequences over a single lysine residue in human serum albumin (Iberg & Fliickiger, 1986) . Human erythrocyte glutathione reductase has such a lysyl-lysine in its catalytic centre involved in nicotinamide binding (Pai et al., 1988) . This is conserved in Escherichia coli glutathione reductase, Trypanosoma congolense trypanothione reductase (Shames et al., 1988) and Pseudomonas aeruginosa glutathione reductase (Perry et al., 1991) . Lysine-66 in human erythrocyte glutathione reductase is involved in nicotinamide binding, whereas lysine-67 is involved in an important intersubunit hydrogen bond to cisproline-468'-O (Karplus & Schulz, 1987) . Binding of a sugar molecule to either of these residues could result in inhibition of enzyme activity. Additionally in the cavity next to lysine-67 of human erythrocyte glutathione reductase is a glutamic acid residue with negative charge (Karplus & Schulz, 1987) . Glucose 6-phosphate could, in addition to blocking the active site, also exert electrostatic repulsion, again disrupting the dimer. Lysine-212 of human erythrocyte glutathione reductase, conserved in E. coli, P. aeruginosa, T. congolense and yeast dihydrolipoamide dehydrogenase, is involved in NADPH binding (Scrutton et al., 1990) . Glycation of this residue could also contribute to inhibition of enzyme activity. Should all these residues be conserved in The elevated levels of glucose, glucose 6-phosphate and fructose in the lens in diabetes could result in the accelerated glycation of lenticular glutathione reductase. As we have shown inhibition of enzyme activity for bovine intestinal glutathione reductase, the enzyme in the lens may similarly be affected, resulting in a decrease in GSH (Scheme 1), providing one possible explanation for early loss of GSH in diabetic cataract.
